Milojevic Milan, Thuijs Daniel J F M, Head Stuart J, Domingues Carina T, Bekker Margreet W A, Zijlstra Felix, Daemen Joost, de Jaegere Peter P T, Kappetein A Pieter, van Domburg Ron T, Bogers Ad J J C
Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands.
Department of Cardiology, Erasmus University Medical Center, Rotterdam, Netherlands.
Interact Cardiovasc Thorac Surg. 2019 Jun 1;28(6):852-859. doi: 10.1093/icvts/ivz006.
Our goal was to evaluate the outcomes of the first patients treated by venous coronary artery bypass grafting (CABG) or percutaneous coronary interventions (PCIs) with balloon angioplasty at a single centre who have reached up to 40 years of life-long follow-up.
We analysed the outcomes of the first consecutive patients who underwent (venous) CABG (n = 1041) from 1971 to 1980 and PCI (n = 856) with balloon angioplasty between 1980 and 1985. Follow-up was successfully achieved in 98% of patients (median 39 years, range 36-46) who underwent CABG and in 97% (median 33 years, range 32-36) of patients who had PCI.
The median age was 53 years in the CABG cohort and 57 years in the PCI cohort. A total of 82% of patients in the CABG group and 37% of those in the PCI group had multivessel coronary artery disease. The cumulative survival rates at 10, 20, 30 and 40 years were 77%, 39%, 14% and 4% after CABG, respectively, and at 10, 20, 30 and 35 years after PCI were 78%, 47%, 21% and 12%, respectively. The estimated life expectancy after CABG was 18 and 17 years after the PCI procedures. Repeat revascularization was performed in 36% and 57% of the patients in the CABG and PCI cohorts, respectively.
This unique life-long follow-up analysis demonstrates that both CABG and PCI were excellent treatment options immediately after their introduction as the standard of care. These procedures were lifesaving, thereby indirectly enabling patients to be treated with newly developed methods and medical therapies during the follow-up years.
我们的目标是评估在单一中心接受静脉冠状动脉旁路移植术(CABG)或经皮冠状动脉介入治疗(PCI)并进行球囊血管成形术的首批患者的治疗结果,这些患者已进行了长达40年的终身随访。
我们分析了1971年至1980年连续接受(静脉)CABG(n = 1041)和1980年至1985年接受PCI(n = 856)并进行球囊血管成形术的首批患者的治疗结果。98%接受CABG的患者(中位随访39年,范围36 - 46年)和97%接受PCI的患者(中位随访33年,范围32 - 36年)成功完成随访。
CABG队列的中位年龄为53岁,PCI队列的中位年龄为57岁。CABG组82%的患者和PCI组37%的患者患有多支冠状动脉疾病。CABG术后10年、20年、30年和40年的累积生存率分别为77%、39%、14%和4%,PCI术后10年、20年、30年和35年的累积生存率分别为78%、47%、21%和12%。CABG和PCI术后的估计预期寿命分别为18年和17年。CABG和PCI队列中分别有36%和57%的患者进行了再次血运重建。
这项独特的终身随访分析表明,CABG和PCI在作为标准治疗方法引入后立即都是出色的治疗选择。这些手术挽救了生命,从而间接使患者在后续几年能够接受新开发的方法和药物治疗。